Literature DB >> 13970703

Normal counterparts to Bence-Jones proteins: free L polypeptide chains of human gamma-globulin.

I BERGGARD, G M EDELMAN.   

Abstract

Entities:  

Keywords:  BENCE JONES PROTEIN; GAMMA GLOBULIN

Mesh:

Substances:

Year:  1963        PMID: 13970703      PMCID: PMC299827          DOI: 10.1073/pnas.49.3.330

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  25 in total

1.  Further studies of the gamma-related proteins of normal urine.

Authors:  G T STEVENSON
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

2.  Reduction of gamma-globulins.

Authors:  J B FLEISCHMAN; R H PAIN; R R PORTER
Journal:  Arch Biochem Biophys       Date:  1962-09       Impact factor: 4.013

3.  On structural and functional relations between antibodies and proteins of the gamma-system.

Authors:  G M EDELMAN; B BENACERRAF
Journal:  Proc Natl Acad Sci U S A       Date:  1962-06-15       Impact factor: 11.205

4.  Detection in normal urine of protein resembling Bence Jones protein.

Authors:  G T STEVENSON
Journal:  J Clin Invest       Date:  1960-07       Impact factor: 14.808

5.  A new supporting medium for preparative electrophoresis.

Authors:  H J MULLER-EBERHARD
Journal:  Scand J Clin Lab Invest       Date:  1960       Impact factor: 1.713

6.  Genetic basis of the thalassaemia diseases.

Authors:  V M INGRAM; A O STRETTON
Journal:  Nature       Date:  1959-12-19       Impact factor: 49.962

7.  Biocolloids in normal human urine. I. Amount and electrophoretic characteristics.

Authors:  T WEBB; B ROSE; A H SEHON
Journal:  Can J Biochem Physiol       Date:  1958-11

8.  Biocolloids in normal human urine. II. Physicochemical and immunochemical characteristics.

Authors:  T WEBB; B ROSE; A H SEHON
Journal:  Can J Biochem Physiol       Date:  1958-11

9.  Formation of Bence-Jones protein and myeloma protein in vitro by the plasma-cell tumour MPC-2.

Authors:  B A ASKONAS; J L FAHEY
Journal:  Biochem J       Date:  1961-08       Impact factor: 3.857

10.  The antigenic structure of the polypeptide chains of human gamma-globulin.

Authors:  D E OLINS; G M EDELMAN
Journal:  J Exp Med       Date:  1962-11-01       Impact factor: 14.307

View more
  16 in total

1.  HETEROGENEITY OF L-CHAIN SITES ON BENCE-JONES PROTEINS REACTING WITH ANTI-GAMMA-GLOBULIN FACTORS.

Authors:  R C WILLIAMS
Journal:  Proc Natl Acad Sci U S A       Date:  1964-07       Impact factor: 11.205

2.  CHARACTERIZATION OF ANTIBODIES IN HUMAN URINE.

Authors:  L A HANSON; E M TAN
Journal:  J Clin Invest       Date:  1965-05       Impact factor: 14.808

Review 3.  THE IMMUNOGLOBULINS, WITH SPECIAL REFERENCE TO MACROGLOBULINS AND MACROGLOBULINEMIA.

Authors:  M R MACKENZIE; H H FUDENBERG
Journal:  Calif Med       Date:  1965-09

4.  Paraproteins, benign or malignant?

Authors:  J R Hobbs
Journal:  Br Med J       Date:  1967-09-16

5.  The properties of isolated serum and urinary antibodies to a single antigen.

Authors:  E Merler
Journal:  Immunology       Date:  1966-03       Impact factor: 7.397

6.  Antibodies of IgA and IgG class in normal human urine.

Authors:  M W Turner; D S Rowe
Journal:  Immunology       Date:  1967-06       Impact factor: 7.397

7.  Serum and urine light chain levels in benign monoclonal gammapathies, multiple myeloma and Waldenström's macroglobulinaemia.

Authors:  F Dammacco; J Waldenström
Journal:  Clin Exp Immunol       Date:  1968-11       Impact factor: 4.330

Review 8.  The immunoglobulins: a review.

Authors:  N H Martin
Journal:  J Clin Pathol       Date:  1969-03       Impact factor: 3.411

9.  Naturally-occurring macroglobulin antibody of foetal origin in the normal human newborn.

Authors:  W V Epstein; S W Fong; M Tan
Journal:  Immunology       Date:  1966-03       Impact factor: 7.397

10.  Quantitative immunological determination of 12 plasma proteins excreted in human urine collected before and after exercise.

Authors:  J Poortmans; R W Jeanloz
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.